Search Results

« Previous | 1 - 10 of 23 | Next »

relevance date ▼ date ▲

Number of results to display per page

10 per page 20 per page 50 per page 100 per page

View results as:

List Slideshow

<span itemprop="name">Association of the Time to Immune Checkpoint Inhibitor (ICI) Initiation and Outcomes With Second Line ICI in Patients With Advanced Urothelial Carcinoma</span>

$<span itemprop="name">A phase II study of buparlisib in relapsed or refractory thymomas</span>$

<span itemprop="name">Novel Insights into the Molecular Regulation of Ribonucleotide Reductase in Adrenocortical Carcinoma Treatment</span>

<span itemprop="name">Statin drugs enhance responses to immune checkpoint blockade in head and neck cancer models</span>

<span itemprop="name">Protocol of DREAM3R: DuRvalumab with chEmotherapy as first-line treAtment in advanced pleural Mesothelioma - a phase 3 randomised trial</span>

<span itemprop="name">Durvalumab with platinum-pemetrexed for unresectable pleural mesothelioma: survival, genomic and immunologic analyses from the phase 2 PrE0505 trial</span>

<span itemprop="name">Phase 1 study of veliparib (ABT-888), a poly (ADP-ribose) polymerase inhibitor, with carboplatin and paclitaxel in advanced solid malignancies</span>

$<span itemprop="name">Treatment of refractory germ cell tumors in children with paclitaxel, ifosfamide, and carboplatin: A report from the Children's Oncology Group AGCT0521 study</span>$

<span itemprop="name">Poorly Differentiated Neuroendocrine Carcinomas of the Pancreas A Clinicopathologic Analysis of 44 Cases</span>

<span itemprop="name">Application of the adult International Germ Cell Classification system to pediatric malignant non-seminomatous germ cell tumors: A report from the children's oncology group</span>

Association of the Time to Immune Checkpoint Inhibitor (ICI) Initiation and Outcomes With Second Line ICI in Patients With Advanced Urothelial Carcinoma

1 of 23

A phase II study of buparlisib in relapsed or refractory thymomas

2 of 23

Novel Insights into the Molecular Regulation of Ribonucleotide Reductase in Adrenocortical Carcinoma Treatment

3 of 23

Statin drugs enhance responses to immune checkpoint blockade in head and neck cancer models

4 of 23

Protocol of DREAM3R: DuRvalumab with chEmotherapy as first-line treAtment in advanced pleural Mesothelioma - a phase 3 randomised trial

5 of 23

Durvalumab with platinum-pemetrexed for unresectable pleural mesothelioma: survival, genomic and immunologic analyses from the phase 2 PrE0505 trial

6 of 23

Phase 1 study of veliparib (ABT-888), a poly (ADP-ribose) polymerase inhibitor, with carboplatin and paclitaxel in advanced solid malignancies

7 of 23

Treatment of refractory germ cell tumors in children with paclitaxel, ifosfamide, and carboplatin: A report from the Children's Oncology Group AGCT0521 study

8 of 23

Poorly Differentiated Neuroendocrine Carcinomas of the Pancreas A Clinicopathologic Analysis of 44 Cases

9 of 23

Application of the adult International Germ Cell Classification system to pediatric malignant non-seminomatous germ cell tumors: A report from the children's oncology group

10 of 23

« Previous
Next »
1 Current Page, Page 1
2
3

Search

Search Constraints

Search Results

Limit your search

Authors

Date

Journal or Parent Publication Title

Type

Publication Version

Keyword